| Download the amazing global Makindo app: ✅ Means NICE/National Guidelines 2026 compliant Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer. |
Related Subjects: |Nikolsky's sign |Koebner phenomenon |Erythema Multiforme |Pyoderma gangrenosum |Erythema Nodosum |Dermatitis Herpetiformis |Lichen Planus |Acanthosis Nigricans |Acne Rosacea |Acne Vulgaris |Alopecia |Vitiligo |Urticaria |Basal Cell Carcinoma |Malignant Melanoma |Squamous Cell Carcinoma |Mycosis Fungoides (Sezary Syndrome) |Xeroderma pigmentosum |Bullous Pemphigoid |Pemphigus Vulgaris |Seborrheic Dermatitis |Pityriasis/Tinea versicolor infections |Pityriasis rosea |Scabies |Dermatomyositis |Toxic Epidermal Necrolysis |Stevens-Johnson Syndrome |Atopic Eczema/Atopic Dermatitis |Psoriasis |Alopecia Areata |Alopecia
🧑⚕️ Alopecia refers to hair loss from the scalp or body. It is classified into scarring (permanent follicle destruction) and non-scarring (potentially reversible). Causes range from genetics and autoimmune disease to drugs, stress, endocrine disorders, and infections. Identifying the type is essential for accurate management and prognosis.
Dihydrotestosterone (DHT) is a potent androgen formed from testosterone by the enzyme 5α-reductase. It binds androgen receptors more strongly than testosterone and acts locally in tissues such as the scalp, prostate, and skin. In hair follicles, DHT shortens the anagen (growth) phase and miniaturises follicles, leading to androgenetic alopecia in genetically susceptible individuals. Clinically, this mechanism underlies male- and female-pattern hair loss, and therapies like finasteride target DHT production to slow hair loss.
| Type of Alopecia | Pathophysiology & Key Features | Management / Red Flags 🚨 |
|---|---|---|
| 💇♂️ Androgenetic Alopecia | DHT-mediated follicle miniaturisation 🧬; men: receding temples/crown; women: diffuse crown thinning. Non-scarring, progressive. | Topical minoxidil ✅; oral finasteride (men) 💊; hair transplantation optional; gentle hair care. Non-urgent. |
| 🩹 Alopecia Areata | Autoimmune T-cell attack on follicles ⚔️; patchy hair loss, exclamation mark hairs, nail pitting; can progress to totalis/universalis. | Topical/intralesional corticosteroids 💉; immunotherapy (diphenylcyprone) for resistant cases; monitor for other autoimmune disease ⚠️. |
| 🌪️ Telogen Effluvium | Premature shift anagen → telogen 💨 due to stress, illness, postpartum, drugs; diffuse shedding, non-scarring, self-limiting. | Reassurance ✅; remove triggers; monitor regrowth; supportive care; usually resolves 3–6 months. |
| 🪢 Traction Alopecia | Chronic mechanical tension on follicles 🔗; hairline recession, broken hairs, scalp tenderness; early = reversible, chronic → scarring. | Stop tight hairstyles ✅; topical steroids if inflamed; hair transplant if chronic; monitor for permanent loss 🚨. |
| 🔥 Scarring Alopecia (Cicatricial) | Permanent follicle destruction by chronic inflammation ⚡ (lichen planopilaris, lupus, burns); shiny scalp, absent follicular openings, erythema, scaling. | Urgent dermatology referral 🚨; systemic/topical immunosuppressants (steroids, hydroxychloroquine, mycophenolate); early intervention critical. |
| 🧴 Non-Scarring Alopecia | Follicles intact; hair loss due to endocrine, nutritional, or medication causes; patchy/diffuse; regrowth possible. | Treat underlying cause ✅ (thyroid, iron, nutrition, meds); topical minoxidil optional; monitor for progression to scarring ⚠️. |